1 / 7

Overview of Mavrilimumab Market in Research Report

Complete report @ http://goo.gl/Eim8Ye "Mavrilimumab (Rheumatoid Arthritis) – Forecast and Market Analysis to 2023" Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. It affects over seven million individuals in the 10MM covered in this report (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and India) and the prevalence is expected to grow to just over 8.5 million individuals by 2023.

chrisbotham
Download Presentation

Overview of Mavrilimumab Market in Research Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Mavrilimumab Market Analysis and Forecast to 2023ByGlobalData Browse More Reports On Life Sciences @ http://www.rnrmarketresearch.com/reports/life-sciences. Single User License: US $3495 Published: Dec 2014 © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  2. Mavrilimumab Market Analysis and Forecast to 2023 Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. It affects over seven million individuals in the 10MM covered in this report (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and India) and the prevalence is expected to grow to just over 8.5 million individuals by 2023. The anti-TNFs have been effective in treating the signs and symptoms of RA and inhibiting progression to erosive bone disease. However, the landscape is quickly changing with the introduction of biosimilars, novel biologics, and a class of oral therapies known as JAK inhibitors, all of which will change the market dynamics between 2013 and 2023. With the anti-TNFs as extremely effective therapies for RA, the market is extremely competitive for new entrants and will undergo further pressure as biosimilars are approved and launch. Complete report available @http://www.rnrmarketresearch.com/mavrilimumab-rheumatoid-arthritis-forecast-and-market-analysis-to-2023-market-report.html. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  3. Mavrilimumab Market Analysis and Forecast to 2023 • Mavrilimumab, also known as CAM3001, is in Phase IIb of development for RA by MedImmune, a subsidiary of AstraZeneca. It is a human mAb targeted against the alpha subunit of the GM-CSF receptor. GM-CSF levels are elevated in the serum, synovial fluid, and synoviocytes of patients with RA. Inhibition of GM-CSF activity is proposed to reduce the activation, differentiation, and recruitment of macrophages and neutrophils in the damaged and inflamed joints of RA patients. • Scope • Overview of Rheumatoid Arthritis, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. • Detailed information on Mavrilimumab including product description, safety and efficacy profiles as well as a SWOT analysis. • Sales forecast for Mavrilimumab for the top 6 countries from 2013 to 2023. • Sales information covered for the US, France, Germany, Italy, Spain and the UK. • Purchase a Copy of this Report @ • http://www.rnrmarketresearch.com/contacts/purchase?rname=312807. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  4. Mavrilimumab Market Analysis and Forecast to 2023 • Reasons to buy • Understand and capitalize by identifying products that are most likely to ensure a robust return. • Stay ahead of the competition by understanding the changing competitive landscape for Rheumatoid Arthritis. • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential. • Make more informed business decisions from insightful and in-depth analysis of Mavrilimumab performance. • Obtain sales forecast for Mavrilimumab from 2013-2023 in top 6 countries (the US, France, Germany, Italy, Spain and the UK). • Inquire for discount on this Report @ • http://www.rnrmarketresearch.com/contacts/discount?rname=312807. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  5. Mavrilimumab Market Analysis and Forecast to 2023 • Table of Contents • 1 Table of Contents 5 • 2 Introduction 10 • 3 Disease Overview 15 • 4 Disease Management 22 • 5 Competitive Assessment 40 • 6 Unmet Need and Opportunity 42 • 7 Pipeline Assessment 54 • 8 Mavrilimumab 62 • 9 Appendix 68 • List of Tables • List of Figures • Inquire for sample of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=312807. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  6. Mavrilimumab Market Analysis and Forecast to 2023 Related Market Reports: PharmaPoint: Rheumatoid Arthritis – Japan Drug Forecast and Market Analysis to 2023 research report is now available with RnRMarketResearch.com @ http://www.rnrmarketresearch.com/pharmapoint-rheumatoid-arthritis-japan-drug-forecast-and-market-analysis-to-2023-market-report.html Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) – Forecast and Market Analysis to 2023 research report is now available with RnRMarketResearch.com @ http://www.rnrmarketresearch.com/rituxanmabthera-rituximab-rheumatoid-arthritis-forecast-and-market-analysis-to-2023-market-report.html © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  7. Mavrilimumab Market Analysis and Forecast to 2023 For more details contact Mr. RiteshTiwari:sales@rnrmarketresearch.com/ +18883915441 RnR Market Research RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnR  Market Research library has syndicated reports by leading market research  publishers across the globe. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

More Related